SYNTHIA is participating in the Health&Tech World Summit 2025, a leading global event shaping the future of AI-driven healthcare transformation, taking place at 16 and 17 December 2025 in Marseille, France. The conference is organized by Care Insight.

SYNTHIA Partner Kalliopi Kastampolidou, INAB | Institute of Applied Biosciences / CERTH | Centre for Research & Technology Hellas, is representing the SYNTHIA consortium and will speak in the session “Navigating the use of generated data and patients in research” .

The session is scheduled for 16 December, from 13:30-17:00 hrs. CET.

 

Kalliopi will outline how SYNTHIA, a multidisciplinary Innovative Health Initiative (IHI) collaboration of 39 partners, is advancing Synthetic Data Generation (SDG) for healthcare.

Kalliopi will bring across the SYNTHIA's overall objective which is to unlock high-quality synthetic data to support personalized medicine, AI development, and clinical research. Furthermore, she will explain how we develop and validates SDG methods across diverse data types and six major disease-specific use cases, lung cancer, breast cancer, multiple myeloma, diffuse large B-cell lymphoma, Alzheimer’s disease, and type 2 diabetes. In addition, she will share insights about the SYNTHIA federated platform offering standardized evaluation workflows and transparent suitability labelling. 

About the Health&Tech World Summit 2025

Now in its 8th edition, the Health&Tech World Summit brings together leading experts from Europe, the U.S., and the MENA region who are driving transformation through AI and health data. The event is known as the global reference point for reimagining health systems with AI and data.

Participants will experience: Two days of immersive programming, including plenary sessions, innovation challenges, collaborative tracks, and on-site hospital visits, Exclusive masterclasses on AI assessment and validation, large-scale organizational transformation, and startup scaling; as well as a high-level network of 300+ decision-makers from 24+ countries, including hospital executives, health-AI leaders, and international investors.